The relationship between colorectal tumor and bowel gas compound
Not Applicable
Recruiting
- Conditions
- colorectal tumor
- Registration Number
- JPRN-UMIN000035342
- Lead Sponsor
- Yokohama City University , Gastroenterological surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 360
Inclusion Criteria
Not provided
Exclusion Criteria
1.Colorectal cancer in past history 2.Infectious enteritis 3.Inframmatory bowel disease 4.Bowel obstruction 5.Other inappropriate patient
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link bowel gas compounds like hydrogen sulfide to colorectal tumor progression in JPRN-UMIN000035342?
How does bowel gas compound analysis compare to standard-of-care diagnostics for early-stage colorectal cancer?
Which biomarkers correlate with specific bowel gas profiles in JPRN-UMIN000035342 colorectal tumor patients?
What adverse events are associated with bowel gas compound monitoring in colorectal cancer patients?
How do VOCs in bowel gas relate to microsatellite instability (MSI) or KRAS mutations in JPRN-UMIN000035342?